Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Mirum Pharmaceuticals Inc increased its cash reserves by 123.69%, or 158.32m. Cash Flow from Financing totalled 336.60m or 180.60% of revenues. In addition the company used 70.94m for operations while cash used for investing totalled 107.20m.
Cash flow per share | -1.63 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 4.84 |
---|---|
Tangible book value per share | -0.4955 |
More ▼
Balance sheet in USDView more
Current ratio | 3.34 |
---|---|
Quick ratio | 3.15 |
Total debt/total equity | 1.33 |
---|---|
Total debt/total capital | 0.5701 |
More ▼